Insiders Xintela AB

Equities

XINT

SE0007756903

Delayed Nasdaq Stockholm Other stock markets 09:25:34 2024-05-15 EDT			5-day change	1st Jan Change
0.24 ^SEK	-3.61%		-7.69%	-11.44%

02-28	Xintela AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
02-20	Xintela Names New Chief Scientific Officer	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xintela Names New Chief Scientific Officer	02-20	MT
Xintela Appoints Lucienne Vonk as Chief Scientific Officer	02-19	CI
Xintela AB Appoints Peter Ekolind as Acting CEO, Effective October 1, 2022	22-09-22	CI
New board of directors appointed in Targ	21-10-29	PU
New board of directors appointed in Targ	21-10-14	PU
Xintela AB Appoints Per Norlén as Chief Medical Officer from 1 July 2021	21-05-04	CI
Xintela Recruits Jeffrey Abbey to Targinta as Senior Management Advisor	20-12-14	CI
Xintela AB Appoints Lars Hedbys to Its Board of Directors	20-11-12	CI
Xintela AB Announces Executive Appointments	20-08-19	CI
Claes Post Decides Not to Stand for Re- Election as Board Member of Xintela AB	19-04-26	CI
Xintela AB Names Sven Kili as Chief Operating Officer	19-04-16	CI
Xintela Appoints Sven Kili as Chief Medical Officer	18-08-28	CI
Xintela AB Announces Resignation of Keld Søndergaard from the Board of Directors	17-10-17	CI
Xintela AB Appoints Liselotte Theorell as Director of Product Development and Quality Management	17-07-17	CI
Xintela AB Nominates Keld Sndergaard as New Board Member	17-05-09	CI
Xintela Recruits Rickard Mosell as Head of Business Development	16-09-12	CI
Xintela AB Appoints Caroline Ehrencrona as Director Clinical Development and Regulatory Affairs	16-06-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW